Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health.
Yue ShiChi Chiu WangLiqun WuYunqing ZhangAimin XuYao WangPublished in: International journal of molecular sciences (2023)
Fatty acid-binding protein-4 (FABP4), commonly known as adipocyte-fatty acid-binding protein (A-FABP), is a pleiotropic adipokine that broadly affects immunity and metabolism. It has been increasingly recognized that FABP4 dysfunction is associated with various metabolic syndromes, including obesity, diabetes, cardiovascular diseases, and metabolic inflammation. However, its explicit roles within the context of women's reproduction and pregnancy remain to be investigated. In this review, we collate recent studies probing the influence of FABP4 on female reproduction, pregnancy, and even fetal health. Elevated circulating FABP4 levels have been found to correlate with impaired reproductive function in women, such as polycystic ovary syndrome and endometriosis. Throughout pregnancy, FABP4 affects maternal-fetal interface homeostasis by affecting both glycolipid metabolism and immune tolerance, leading to adverse pregnancy outcomes, including miscarriage, gestational obesity, gestational diabetes, and preeclampsia. Moreover, maternal FABP4 levels exhibit a substantial linkage with the metabolic health of offspring. Herein, we discuss the emerging significance and potential application of FABP4 in reproduction and pregnancy health and delve into its underlying mechanism at molecular levels.
Keyphrases
- pregnancy outcomes
- binding protein
- fatty acid
- pregnant women
- insulin resistance
- polycystic ovary syndrome
- public health
- healthcare
- type diabetes
- mental health
- cardiovascular disease
- health information
- high fat diet
- metabolic syndrome
- weight gain
- oxidative stress
- adipose tissue
- weight loss
- human health
- health promotion
- emergency department
- dna methylation
- physical activity
- risk assessment
- mass spectrometry
- gene expression
- human immunodeficiency virus
- early onset
- molecular dynamics simulations
- hiv infected